+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Significance of Low-Dose and Standard-Dose ACTH Tests Compared to Overnight Metyrapone Test in the Diagnosis of Adrenal Insufficiency in Childhood

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Objective: To discover the value of low-dose (LDAT) and standard-dose ACTH tests (SDAT) as compared with the metyrapone test in the diagnosis of secondary adrenal insufficiency. Patients and Methods: LDAT (0.5 µg/m<sup>2</sup>), SDAT (250 µg/m<sup>2</sup>) and overnight metyrapone (30 mg/kg) tests were carried out in 29 patients with suspected adrenal insufficiency. LDAT and SDAT were also performed in 36 control subjects. Results: 18 of 29 patients were grouped in the adrenal-sufficient (AS) group and 11 of 29 patients in the adrenal-deficient (AD) group according to the metyrapone test results. The control group had significantly higher cortisol responses than the AS and AD groups during LDAT. The control group had similar cortisol responses to the AS group but higher cortisol responses than the AD group during SDAT. The AS group was divided into 2 subgroups: AS patients with multiple pituitary hormone deficiencies (AS-multiple) and AS patients with idiopathic growth hormone deficiencies (AS-isolated). The AS-multiple group had statistically lower cortisol responses than the control group during LDAT. Receiver-operating characteristics analysis revealed that the cortisol cutoff value in LDAT was 19.8 µg/dl (100% sensitivity, 89% specificity) and 30.4 µg/dl in SDAT (82% sensitivity, 78% specificity). Conclusion: LDAT is capable of identifying patients with adrenal insufficiency more effectively than SDAT. The cortisol cutoff value in LDAT was calculated as 19.8 µg/dl with 100% sensitivity. AS patients with multiple pituitary hormone deficiencies had lower cortisol responses to LDAT than the control group implying that these patients might have a lower cortisol secretory capacity than healthy subjects.

          Related collections

          Most cited references 10

          • Record: found
          • Abstract: not found
          • Article: not found

          Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids

           J Broide (1995)
            • Record: found
            • Abstract: not found
            • Article: not found

            The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases

             K Tordjman (1995)
              • Record: found
              • Abstract: not found
              • Article: not found

              Clinical review 62: Laboratory assessment of adrenal insufficiency

               S Grinspoon (1994)

                Author and article information

                Horm Res Paediatr
                Hormone Research in Paediatrics
                S. Karger AG
                15 October 2003
                : 60
                : 4
                : 191-197
                Department of Pediatric Endocrinology, Hacettepe University Faculty of Medicine, Ankara, Turkey
                73232 Horm Res 2003;60:191–197
                © 2003 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                Page count
                Figures: 4, Tables: 1, References: 24, Pages: 7
                Original Paper


                Comment on this article